Cure My Disease

Don't miss your cure!

 Log in / Sign up

Menopause support designed by and for indigenous women heads to trial

NCT ID NCT07713095

Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study tests whether a program called Waning Moon is practical and well-liked by urban American Indian and Alaska Native women going through menopause. The program includes four weekly group sessions led by community health workers, covering menopause education, mindfulness, self-acupressure, and group support. Thirty women aged 35 to 65 who are experiencing menopause symptoms will take part. The goal is to see if this culturally tailored approach is a good fit for the community.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a culturally tailored integrative medical group visit program called Waning Moon (MENOGAP), consisting of four weekly 90-minute sessions covering menopause education, mindfulness, self-acupressure, and group discussion
What this could lead to
If successful, this program could offer a culturally appropriate way to ease menopause symptoms and improve well-being for urban American Indian/Alaska Native women.
What could go wrong
This is a small feasibility study with only 30 participants, so results may not apply broadly. The program's effectiveness for symptom relief has not yet been proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identifies as American Indian or Alaska Native * Female, age 35-65 * Experiencing menopause-related symptoms (e.g., vasomotor symptoms) * Able to attend sessions at Urban Indian Center of Salt Lake in Salt Lake City, Utah * English-speaking Exclusion Criteria: * Currently enrolled in another menopause intervention study * Does not identify as American Indian or Alaska Native * Not experiencing menopause

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for American indian or alaska native are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

American indian or alaska native Health disparities Menopause Vasomotor symptoms (VMS) Women's health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.